Bio-Techne (TECH) reported fiscal Q2 adjusted earnings Wednesday of $0.42 per diluted share, up from $0.40 a year earlier.
Analysts polled by FactSet expected $0.39.
Net sales for the quarter ended Dec. 31 were $297 million, up from $272.6 million a year earlier.
Analysts surveyed by FactSet expected $285.8 million.
The company's shares were up nearly 6% in recent premarket activity.
Price: 76.79, Change: +4.24, Percent Change: +5.8